Virginia Commonwealth University

VCU Massey Cancer Center

Massey Clinical Trial Concept Program

Massey Translational Clinical Trial Concept Program

The Massey Cancer Center provides support for development of approved, translational clinical trial concepts based on laboratory discoveries of MCC Scientific Program investigators, into innovative early phase clinical trials, projects that advance discoveries from our laboratories to our patients.

Massey members and associate members are eligible to apply for MCC support by developing and submitting translational concepts for review by the Clinical Trial Concept Review Committee (CTCRC).  Approved concepts receive support of MCC Scientific Writer and other clinical research support to develop a preliminary protocol and budget for submission to external sponsors for drug supply and partial funding.  Once drug supply and external support level have been identified, the preliminary concept and the developed budget will undergo a second CTCRC review for final approval for full protocol development and clinical research staff support if PRMC approval for activation is forthcoming.  If additional preclinical studies are needed to procure drug supply, a request for funding support with a budget may be included with the resubmission.

MCC is now soliciting submissions of proposed concepts for translational clinical trials, which are to be submitted no later than October 14, 2016 for review at the October 25th meeting of the CTCRC.

For questions regarding the Massey Translational Clinical Trial Concept Program please contact:

Martha Wellons
Director, Clinical trial development and program management
(804) 628-1939
mwellons@vcu.edu

The Call for Translational Clinical Trial Concepts and the Submission Form are available below.

Call for Translational Clinical Trial Concepts

Translational Clinical Trial Concepts Submission Form

Massey Clinical Trial Concept Program

While Translational Trial Concepts bringing Massey discoveries into the clinic receive the highest priority for activation, Massey leadership recognizes the importance of also supporting Clinical Trial concepts developed by our clinical investigators for career development and maintaining a robust IIT portfolio.  

Massey leadership is implementing a system for review of proposed Clinical Trial concepts by the Clinical Trial Concept Review Committee that currently reviews Translational Trial concepts.   The criteria for review will be similar, but will not require the scientific basis for the trial to have been developed by Massey investigators.

Approved concepts receive support of the MCC Scientific Writers and other Clinical Trial Office support to develop an approved concept into a preliminary protocol and budget for submission to external sponsors for drug supply and partial funding.  Once drug supply and external support level have been identified, the preliminary concept and the proposed budget will undergo a second CTCRC review for final approval for full protocol development required for submission to PRMC.  Protocols approved by PRMC for activation will receive the CTO support specified in the approved budget for conduct, analysis and reporting of the trial.

MCC is now soliciting submissions of proposed concepts for clinical trials, which are to be submitted no later than October 14, 2016 for review at the October 25th meeting of the CTCRC.

For questions regarding the Massey Translational Clinical Trial Concept Program please contact:

Martha Wellons
Director, Clinical Trial Development and Program Management
(804) 628-1939
mwellons@vcu.edu 

The Call for Clinical Trial Concepts and the Submission Form are available below.

Call for Clinical Trial Concepts

Clinical Trial Concept Submission Form